Medtronic Inc. (MDT)
the world’s largest maker of heart-maker devices, won U.S. regulatory
approval for the first artificial pancreas system that automatically
stops insulin delivery to diabetics when glucose levels reach a certain
point. http://www.pradika.com/story.php?title=kyle-leon-scam
The MiniMed 530G with Enlite was approved for use by people with
diabetes who are at least 16 years old, the Minneapolis-based company
said in a statement today. http://luislauro.us/story.php?title=kyle-leon-scam
The device’s improved accuracy and ability to shut itself off for
two hours builds on existing machines, which sound an alarm when glucose
levels get to a preset level.
No comments:
Post a Comment